[go: up one dir, main page]

AU2002212187A1 - Diagnosis of illnesses or predisposition to certain illnesses - Google Patents

Diagnosis of illnesses or predisposition to certain illnesses

Info

Publication number
AU2002212187A1
AU2002212187A1 AU2002212187A AU1218702A AU2002212187A1 AU 2002212187 A1 AU2002212187 A1 AU 2002212187A1 AU 2002212187 A AU2002212187 A AU 2002212187A AU 1218702 A AU1218702 A AU 1218702A AU 2002212187 A1 AU2002212187 A1 AU 2002212187A1
Authority
AU
Australia
Prior art keywords
illnesses
predisposition
diagnosis
certain
certain illnesses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212187A
Other languages
English (en)
Inventor
Kurt Berlin
Alexander Olek
Christian Piepenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2002212187A1 publication Critical patent/AU2002212187A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002212187A 2000-09-01 2001-09-01 Diagnosis of illnesses or predisposition to certain illnesses Abandoned AU2002212187A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10043826.1 2000-09-01
DE10043826 2000-09-01
PCT/EP2001/010073 WO2002018631A2 (fr) 2000-09-01 2001-09-01 Diagnostic de maladies declarees ou de la predisposition a certaines maladies

Publications (1)

Publication Number Publication Date
AU2002212187A1 true AU2002212187A1 (en) 2002-03-13

Family

ID=7655132

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212187A Abandoned AU2002212187A1 (en) 2000-09-01 2001-09-01 Diagnosis of illnesses or predisposition to certain illnesses

Country Status (5)

Country Link
US (1) US20050064401A1 (fr)
EP (1) EP1373564A2 (fr)
JP (1) JP2005512499A (fr)
AU (1) AU2002212187A1 (fr)
WO (1) WO2002018631A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP0855184A1 (fr) * 1997-01-23 1998-07-29 Grayson B. Dr. Lipford Composition pharmaceutique comprenant un polynucléotide et un antigène notamment pour la vaccination
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US20040131628A1 (en) * 2000-03-08 2004-07-08 Bratzler Robert L. Nucleic acids for the treatment of disorders associated with microorganisms
KR100917101B1 (ko) * 2000-08-04 2009-09-15 도요 보세키 가부시키가이샤 플렉시블 금속적층체 및 그 제조방법
US7576066B2 (en) * 2002-07-03 2009-08-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7569553B2 (en) * 2002-07-03 2009-08-04 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7605138B2 (en) * 2002-07-03 2009-10-20 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7807803B2 (en) * 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en) * 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
AU2003257587A1 (en) * 2002-08-23 2004-03-11 Japan As Represented By President Of National Cancer Center Method of evaluating degree of canceration of human-origin specimen
CN101948835A (zh) * 2002-10-29 2011-01-19 科勒制药集团股份有限公司 Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
WO2004053104A2 (fr) * 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. Acides nucleiques 5'cpg et leurs methodes d'utilisation
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
SG173219A1 (en) * 2002-12-23 2011-08-29 Dynavax Tech Corp Immunostimulatory sequence oligonucleotides and methods of using the same
US20040235770A1 (en) * 2003-04-02 2004-11-25 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
US20050013812A1 (en) * 2003-07-14 2005-01-20 Dow Steven W. Vaccines using pattern recognition receptor-ligand:lipid complexes
KR100558851B1 (ko) * 2004-01-08 2006-03-10 학교법인연세대학교 면역조절능력이 증가된 ＣｐＧ 올리고데옥시뉴클레오티드변형체
EP2013360A2 (fr) * 2006-04-17 2009-01-14 Epigenomics AG Procédés et acides nucléiques pour détecter des troubles de prolifération de cellules colorectales
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
EP2229456A2 (fr) * 2007-12-11 2010-09-22 Epigenomics AG Methodes et acides nucleiques permettant d'analyser les troubles de la proliferation cellulaire
EP2250287B1 (fr) * 2008-02-19 2013-09-18 MDxHealth SA Détection et pronostic de cancer du poumon
WO2010028256A2 (fr) * 2008-09-05 2010-03-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biomarqueurs prédictifs
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US20120164238A1 (en) 2009-02-03 2012-06-28 Mdxhealth Sa Methods of detecting colorectal cancer
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
ES2669439T3 (es) * 2009-06-26 2018-05-25 Epigenomics Ag Métodos y ácidos nucleicos para el análisis del carcinoma de vejiga
EP2707506B1 (fr) * 2011-05-12 2018-07-11 The Johns Hopkins University Procédé de détection d'un cancer par l'intermédiaire d'une perte généralisée de stabilité de domaines épigénétiques, et compositions associées
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer
EP3889611A1 (fr) * 2014-12-12 2021-10-06 Exact Sciences Development Company, LLC Compositions et procédés pour effectuer des essais de détection de méthylation
WO2016094839A2 (fr) * 2014-12-12 2016-06-16 Exact Sciences Corporation Compositions et méthodes pour mettre en oeuvre des dosages de détection de méthylation
EP3274440A4 (fr) 2015-03-27 2019-03-06 Exact Sciences Corporation Détection de troubles de l' sophage
DE102015009187B3 (de) * 2015-07-16 2016-10-13 Dimo Dietrich Verfahren zur Bestimmung einer Mutation in genomischer DNA, Verwendung des Verfahrens und Kit zur Durchführung des Verfahrens
PL3336197T3 (pl) 2016-12-16 2022-08-08 Eurofins Genomics Europe Sequencing GmbH Markery epigenetyczne oraz powiązane sposoby i środki wykrywania i leczenia raka jajnika
CN111635938B (zh) * 2020-04-30 2022-07-29 广州康立明生物科技股份有限公司 一种肿瘤检测试剂及试剂盒
CN111676287B (zh) * 2020-06-03 2022-04-29 广州康立明生物科技股份有限公司 一种基因标志物组合及其应用
CN112195243A (zh) * 2020-09-22 2021-01-08 北京华大吉比爱生物技术有限公司 一种检测多基因甲基化的试剂盒及其应用
WO2023122508A2 (fr) * 2021-12-23 2023-06-29 Mammoth Biosciences, Inc. Améliorations de dosage basé sur une nucléase programmable

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0730663B1 (fr) * 1993-10-26 2003-09-24 Affymetrix, Inc. Reseaux de sondes d'acide nucleique sur des microplaquettes biologiques
DE19754482A1 (de) * 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke

Also Published As

Publication number Publication date
JP2005512499A (ja) 2005-05-12
US20050064401A1 (en) 2005-03-24
WO2002018631A3 (fr) 2003-10-16
EP1373564A2 (fr) 2004-01-02
WO2002018631A2 (fr) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2002212187A1 (en) Diagnosis of illnesses or predisposition to certain illnesses
AUPR005600A0 (en) Diagnostic assay
AU2002239370A1 (en) Signal tampon
AU4671401A (en) Bodily flow measuring system
AUPR605601A0 (en) Pipeite of sandwich construction
AU2001252367A1 (en) Improvements relating to computer systems
AU2002234169A1 (en) Measurement of electrophysiologic response
AU2002359986A1 (en) Period indicator
AU1718301A (en) Use of sugar compositions
AU2001291761A1 (en) Microcapsules
AU2002362157A1 (en) Indicator
EP1126339A3 (fr) Chronomètre
AU2001232105A1 (en) Improvements relating to data filtering
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002220913A1 (en) Improvements relating to thermometers
AU2001281123A1 (en) Haplotypes of the isl1 gene
AU2002222116A1 (en) Improvements relating to information systems
AU2001286890A1 (en) Haplotypes of the scya2 gene
AU2002216038A1 (en) Preparation of monofluoroalkenes
AU2001289288A1 (en) Improvements relating to information systems
AU2002342334A1 (en) Obtaining information to facilitate system usage
AU2002239511A1 (en) Haplotypes of the gsr gene
AU2002334465A1 (en) Improvement to instrumentation
GB9924457D0 (en) Improvements to the transmission of information
AU2001284319A1 (en) Improvements relating to information exchange systems

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application